Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secretome supplementation in acute exacerbations of COPD: inflammatory marker changes
TCTR20230712001Phase 3Completed
- Sponsor
- Universitas Sebelas Maret
- Start
- Jan 2023
- Countries
- 1
01
Overview
Phase 3 trial in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Universitas Sebelas Maret. Primary endpoints: Change in interleukin-6 (IL-6) levels, Change in tumor necrosis factor (TNF) levels and 1 more. Started Jan 2023; status: completed.
02
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on TCTR20230712001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230712001.